Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Zolk

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Circulation|March 14, 1998
Endothelin receptors in the failing and nonfailing human heartK Pönicke, M Vogelsang, M Heinroth, et al.
Circulation|April 27, 1999
Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failureO Zolk, J Quattek, G Sitzler, et al.
Hypertension (Dallas, Tex. : 1979)|October 6, 1997
Contractile systolic and diastolic dysfunction in renin-induced hypertensive cardiomyopathyM Flesch, F Schiffer, O Zolk, et al.
British Journal of Pharmacology|March 21, 1998
Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 ratsO Zolk, M Flesch, P Schnabel, et al.
British Journal of Pharmacology|October 4, 2000
The effect of Gi-protein inactivation on basal, and beta(1)- and beta(2)AR-stimulated contraction of myocytes from transgenic mice overexpressing the beta(2)-adrenoceptorH Gong, D L Adamson, H K Ranu, et al.
Cardiovascular Research|January 7, 1999
Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophyM Böhm, S Ettelbrück, M Flesch, et al.
Circulation|May 20, 1999
Myocardial dysfunction in donor hearts. A possible etiologyV J Owen, P B Burton, M C Michel, et al.
Critical Reviews in Oncology/Hematology|May 16, 2018
The influence of genetic variation on late toxicities in childhood cancer survivors: A reviewE Clemens, A L F van der Kooi, L Broer, et al.
NPJ Precision Oncology|July 15, 2021
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE studyA J M Meijer, F A Diepstraten, T Langer, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Circulation|March 14, 1998
Endothelin receptors in the failing and nonfailing human heartK Pönicke, M Vogelsang, M Heinroth, et al.
Circulation|April 27, 1999
Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failureO Zolk, J Quattek, G Sitzler, et al.
Hypertension (Dallas, Tex. : 1979)|October 6, 1997
Contractile systolic and diastolic dysfunction in renin-induced hypertensive cardiomyopathyM Flesch, F Schiffer, O Zolk, et al.
British Journal of Pharmacology|March 21, 1998
Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 ratsO Zolk, M Flesch, P Schnabel, et al.
British Journal of Pharmacology|October 4, 2000
The effect of Gi-protein inactivation on basal, and beta(1)- and beta(2)AR-stimulated contraction of myocytes from transgenic mice overexpressing the beta(2)-adrenoceptorH Gong, D L Adamson, H K Ranu, et al.
Cardiovascular Research|January 7, 1999
Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophyM Böhm, S Ettelbrück, M Flesch, et al.
Circulation|May 20, 1999
Myocardial dysfunction in donor hearts. A possible etiologyV J Owen, P B Burton, M C Michel, et al.
Critical Reviews in Oncology/Hematology|May 16, 2018
The influence of genetic variation on late toxicities in childhood cancer survivors: A reviewE Clemens, A L F van der Kooi, L Broer, et al.
NPJ Precision Oncology|July 15, 2021
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE studyA J M Meijer, F A Diepstraten, T Langer, et al.
Pageof 4